Charles N. Mills bought $75M of MDLN
director at Medline Inc.. 2,579,310 shares at an average of $29.00, traded Dec 18, 2025, filed Dec 22, 2025.
Score components
- +15RoleDirector
- +25Trade size$74.8M at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +10Price context0% above the 52-week low
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-328813, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2025 | AGrant or award Class B Common Stockindirect: See Footnote | +64,005 | - | - | 64,005 | Dec 22, 2025 |
| Dec 18, 2025 | POpen-market purchase Class A Common Stockindirect: See Footnote | +2,441,379 | $29.00 | $71M | 2,441,379 | Dec 22, 2025 |
| Dec 18, 2025 | POpen-market purchase Class A Common Stockindirect: By Spouse | +137,931 | $29.00 | $4.0M | 137,931 | Dec 22, 2025 |
| Dec 16, 2025 | AGrant or award Common Units of Medline Holdings, LPderivativeindirect: See Footnote | +64,005 | - | - | 64,005 | Dec 22, 2025 |
Related signals
Other insiders at Medline Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | MDLNsell Medline Inc. | GIC Private Ltd owner | $722M 20,678,630 shares | -91% | |
| 57Moderate | Medline Inc. | BCP 8 Holdings Mozart Manager L.L.C. owner | $1.1B 27,852,986 shares | -22% | |
| 57Moderate | Medline Inc. | BX Mozart ML-2 Holdco L.P. owner | $1.1B 27,852,986 shares | -22% | |
| 57Moderate | Medline Inc. | Carlyle Group Inc. owner | $1.1B 26,105,840 shares | -17% | |
| 57Moderate | Medline Inc. | CP Circle ML Holdco GP, LLC owner | $1.1B 26,105,840 shares | -17% | |
| 57Moderate | Medline Inc. | Carlyle Mozart Coinvestment Holdings, L.P. owner | $1.1B 26,105,840 shares | -17% | |
| 57Moderate | Medline Inc. | TC Group Cayman Investment Holdings, L.P. owner | $1.1B 26,105,840 shares | -17% | |
| 72Notable | Medline Inc. | Hellman & Friedman Capital Partners X (Parallel), L.P. owner | $1.1B 26,131,237 shares | -172% | |
| 52Moderate | Medline Inc. | Mozart Aggregator II LP owner | $382M 13,462,600 shares | -9% | |
| 57Moderate | Medline Inc. | Carlyle Group Inc. owner | $555M 19,136,333 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.